Stockreport

PepGen Plunges On Mixed Phase 2 Data, But Higher Dose Could Offer Some Relief [Seeking Alpha]

PepGen Inc.  (PEPG) 
PDF PGN-EDODM1 showed clean safety and biological activity, but efficacy was pretty modest and skewed by an outlier. So that higher 10 mg/kg dose is the next key catalyst. [Read more]